Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Cyclacel Boosts Clinical Work With $45M Private Placement

April 28, 2006

By Jennifer Boggs

For Replikins, Replication Data Allow For Predicting Epidemics

April 27, 2006

By Jennifer Boggs

FivePrime, BI Enter Deal In RA Worth Up To $75M

April 27, 2006

By Jennifer Boggs

Financings roundup: Light Sciences Oncology files to raise $86M in IPO

April 27, 2006

By Jennifer Boggs

For Replikins, Replication Data Allow For Predicting Epidemics

April 27, 2006

By Jennifer Boggs

FivePrime, BI Enter Deal In RA Worth Up To $75M

April 27, 2006

By Jennifer Boggs

Light Sciences Oncology Files To Raise $86M In IPO

April 26, 2006

By Jennifer Boggs

Light Sciences Oncology Files To Raise $86M In IPO

April 26, 2006

By Jennifer Boggs

ConjuGon Developing 'Trojan Horse' For Resistant Bacteria

April 25, 2006

By Jennifer Boggs

ConjuGon Developing 'Trojan Horse' For Resistant Bacteria

April 25, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...